<DOC>
	<DOCNO>NCT01309048</DOCNO>
	<brief_summary>This study confirm safety technical MRI guide High Intensity Focused Ultrasound ( HIFU ) Palliation Pain Skeletal Metastases . MRI guide high intensity focus ultrasound us ultrasound heat thermally ablate tissue . The MRI system identifies ultrasound path monitor heat rise tissue . The goal study show treatment safety effectiveness . MR-guided HIFU perform patient pass inclusion/exclusion criterion .</brief_summary>
	<brief_title>Magnetic Resonance-Guided High Intensity Focused Ultrasound Palliation Painful Skeletal Metastases</brief_title>
	<detailed_description>Bone metastasis common among patient advanced cancer report 85 % cancer patient autopsy . Complications bone metastasis include pain , functional limitation , decrease quality life , pathological fracture , spinal cord compression cauda equina syndrome . External beam radiotherapy current standard treatment patient painful uncomplicated bone metastasis . Unfortunately 30 % patient treated radiotherapy respond therapy , 30 % responder pain recur point treatment . Radiotherapy re-treatment also limit cumulative dos deliver sensitive structure . Ablative technique cryotherapy percutaneous radiofrequency ablation similarly limit cumulative effect , however , invasive procedure place patient risk complication . MR-guided high intensity focus ultrasound ( MR-HIFU ) non-invasive , outpatient modality investigate treatment cancer . In MR-HIFU , specially design transducer use focus beam ultrasound energy small volume specific target site body . The focused beam produce therapeutic hyperthermia target field harmlessly warm immediately surrounding tissue . Magnetic resonance ( MR ) image use focus ultrasound beam target field bone ( metastatic lesion adjacent periosteum contain nerve vasculature tumor ) perform real-time thermal mapping around target . The mechanism action pain response think thermal periosteal denervation / thermal ablation tumor mass diminish pressure surround tissue .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<criteria>Age ≥18 year Able give inform consent Weight &lt; 140kg Radiologic evidence bone metastasis solid tumor Able characterize pain specifically site interest ( target lesion ) Pain score relate target lesion ≥4 010 point scale irrespective medication Target lesion accessible MRHIFU procedure Target lesion maximum dimension ≤8cm Target lesion uncomplicated ( i.e . : fracture / spinal cord compression / cauda equina syndrome / soft tissue component ) Target lesion visible noncontrast MRI Interface bone skin lie ≥1cm surface Able communicate sensation MRHIFU treatment MRHIFU treatment date ≥2 week recent treatment primary tumor chemotherapy . Prior radiotherapy / surgery / ablative therapy / local therapy target lesion . Unable characterize pain specifically site interest ( target lesion ) Pregnant / Nursing woman Target lesion complicate ( i.e . : presence one fracture / spinal cord compression / cauda equina syndrome / soft tissue component ) . Target lesion &lt; 1cm nerve bundle / bladder / bowel Target lesion contact hollow viscera Target lesion locate skull , spine ( exclude sacrum allow ) sternum Scar along propose HIFU beam path Orthopaedic implant along propose HIFU beam path site target lesion . Serious cardiovascular , neurological , renal hematological chronic disease Active infection Unable tolerate require stationary position treatment Allergy MRI contrast agent sedation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>bone metastasis</keyword>
	<keyword>Patients bone metastasis</keyword>
</DOC>